Skip to Main Content
Practices
Appellate Litigation
Banking & Financial Institutions
Capital Markets
Commercial Litigation
Commercial Real Estate
Emerging Companies & Venture Capital
Employee Benefits & Executive Compensation
Environmental, Regulatory & Administrative Law
Family Law
Government Contracting
Healthcare
Investment Funds
Labor & Employment
Licensing & Technology Transactions
Mergers & Acquisitions
Privacy & Data Security
Tax
Trademarks
Trusts & Estates
People
Careers
News & Insights
Our Firm
Search
919.781.4000
Online Payment
Contact Us
GlaxoSmithKline sale of US rights for three products to CorePharma
GlaxoSmithKline
has sold the US rights for
Dexedrine®SPANSULE®,
Albenza® and Daraprim®
to
CorePharma
Search
